Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bunazosin vs Doxazosin Add-on to Valsartan in Hypertension
NCT00130156Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2005
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bunazosin in essential hypertension (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Systolic and Diastolic Blood Pressure at Week 13. Started Oct 2005; status: completed.
02
Drugs
bunazosin
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00130156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130156.